Perrigo Ordinary Shares reported $140.7M in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbott ABT:US USD 2.5B 703M
Bayer BAYN:GR EUR 2.45B 2.31B
Bristol Myers Squibb BMY:US USD 5.32B 456M
Catalent CTLT:US USD 161M 200M
Corcept Therapeutics CORT:US USD 32.13M 581K
Dr.Reddys Laboratories DRRD:IN INR 19.01B 9.6B
Eli Lilly And LLY:US USD 2.31B 308.9M
Endo International Ordinary Shares ENDP:US USD 151.76M 22.28M
Horizon Pharma HZNP:US USD 287.24M 42.81M
Johnson & Johnson JNJ:US USD 7.81B 876M
Lannett LCI:US USD -10082000 6.25M
Pacira Pharmaceuticals PCRX:US USD 41.98M 7.94M
Perrigo Ordinary Shares PRGO:US USD 140.7M 54.6M
Pfizer PFE:US USD 10.52B 2.78B
Prestige Brands PBH:US USD 92.63M 2.77M
Reckitt Benckiser Group PLC RB/:LN GBP 1.96B 275M
Teva Pharmaceutical TEVA:IT USD 1.06B 31M
Xeris Pharmaceuticals Inc XERS:US USD -16069000 215K
Zoetis ZTS:US USD 840M 14M